EKF Diagnostics to expand hemoglobin production capacity at Barleben site by 30%

EKF Diagnostics will invest to increase hemoglobin consumable and analyzer production capacity at its Barleben, Germany site by 30% as part of a five-year strategic plan.

“Further investment will be deployed to grow hemoglobin consumable and analyser production capacity at its Barleben site in Germany by 30% as part of the five-year strategic development plan for the business.”business-live.co.uk

• 1 source
• business-live.co.ukMajor contract wins for diagnostics firm EKF in Africa and Latin America | Business LiveSion BarryAug 26, 2025

Summarized from public sources; check the original articles before acting on it.